ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $148M (100.0% shares, 0.0% debt)

Holdings (35)

APLS APELLIS PHARMACEUTICALS INC 18.4%
Value $27.11M Shares 297,596 Est. Cost $44.70 Unrealized +93.0%
WHWK AADI BIOSCIENCES INC 8.6%
Value $12.65M Shares 1,849,402 Est. Cost $27.48 Unrealized -71.7%
TERN TERNS PHARMACEUTICALS INC 5.8%
Value $8.488M Shares 970,000 Est. Cost $5.72 Unrealized +103.8%
KURA KURA ONCOLOGY INC. COMMON STOCK 5.1%
Value $7.502M Shares 709,118 Est. Cost $14.15 Unrealized -16.4%
SNDX SYNDAX PHARMACEUTICALS INC 4.3%
Value $6.276M Shares 299,841 Est. Cost $19.65 Unrealized +5.9%
IRON DISC MEDICINE INC 4.2%
Value $6.194M Shares 139,500 Est. Cost $35.48 Unrealized 0.0%
PCVX VAXCYTE INC 4.1%
Value $6.101M Shares 122,166 Est. Cost $31.29 Unrealized +51.5%
RCKT ROCKET PHARMACEUTICALS INC 4.1%
Value $6.084M Shares 306,194 Est. Cost $18.61 Unrealized +8.6%
VRDN VIRIDIAN THERAPEUTICS INC 3.6%
Value $5.346M Shares 224,707 Est. Cost $19.84 Unrealized +29.3%
IVERIC BIO INC 3.5%
Value $5.171M Shares 131,454 Est. Cost $7.63 Unrealized
ARGX ARGENX SE 3.3%
Value $4.898M Shares 12,568 Est. Cost $379.17 Unrealized
PRAXIS PRECISION MEDICINES I 3.3%
Value $4.888M Shares 4,250,000 Est. Cost $1.15 Unrealized
VTYX VENTYX BIOSCIENCES INC 3.3%
Value $4.832M Shares 147,318 Est. Cost $21.58 Unrealized +59.8%
CYMABAY THERAPEUTICS INC. COMMON STOCK 3.2%
Value $4.708M Shares 430,000 Est. Cost $6.27 Unrealized
CLDX CELLDEX THERAPEUTICS INC 2.8%
Value $4.151M Shares 122,343 Est. Cost $9.46 Unrealized +256.2%
CLENE INC 2.5%
Value $3.732M Shares 4,240,846 Est. Cost $0.88 Unrealized
IKENA ONCOLOGY INC 2.5%
Value $3.66M Shares 558,000 Est. Cost $6.56 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 2.3%
Value $3.323M Shares 382,000 Est. Cost $10.15 Unrealized -39.8%
GHRS GH RESEARCH PLC 2.0%
Value $2.905M Shares 244,828 Est. Cost $20.48 Unrealized -49.9%
IMVT IMMUNOVANT INC 1.8%
Value $2.689M Shares 141,755 Est. Cost $18.65 Unrealized 0.0%
VSTM VERASTEM INC 1.5%
Value $2.232M Shares 300,000 Est. Cost $6.94 Unrealized 0.0%
ROIV ROIVANT SCIENCES LTD 1.5%
Value $2.218M Shares 220,000 Est. Cost $8.94 Unrealized 0.0%
ELVN ENLIVEN THERAPEUTICS INC 1.4%
Value $2.133M Shares 104,500 Est. Cost $20.25 Unrealized -0.2%
ALKS ALKERMES PLC 0.9%
Value $1.399M Shares 44,689 Est. Cost $28.13 Unrealized +7.6%
ACRS ACLARIS THERAPEUTICS 0.9%
Value $1.262M Shares 121,692 Est. Cost $16.22 Unrealized -44.2%
HILLEVAX INC 0.7%
Value $1.084M Shares 63,078 Est. Cost $17.12 Unrealized
MORPHIC HOLDING INC 0.7%
Value $1.003M Shares 17,500 Est. Cost $57.33 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS INC 0.7%
Value $981K Shares 27,500 Est. Cost $34.48 Unrealized 0.0%
OLMA OLEMA PHARMACEUTICALS INC 0.6%
Value $956K Shares 105,814 Est. Cost $6.04 Unrealized 0.0%
BMEA BIOMEA FUSION INC 0.6%
Value $878K Shares 40,000 Est. Cost $31.30 Unrealized 0.0%
DYN DYNE THERAPEUTICS INC 0.6%
Value $821K Shares 73,000 Est. Cost $11.80 Unrealized 0.0%
RZLT REZOLUTE INC 0.5%
Value $739K Shares 373,400 Est. Cost $3.30 Unrealized -37.6%
SVRA SAVARA INC 0.4%
Value $633K Shares 198,139 Est. Cost $2.25 Unrealized +4.3%
KRONOS BIO INC 0.4%
Value $542K Shares 315,000 Est. Cost $1.72 Unrealized
NUVATION BIO INC 0.0%
Value $15,023 Shares 90,832 Est. Cost $0.28 Unrealized